Twenty-one pregnant women were studied to determine the distribution of herpes simplex virus (HSV): 10 had symptomatic genital herpes, including 1 with primary cervical HSV infection, and 11 had asymptomatic genital herpes. Samples from vesicles, the cervix, and amniotic fluid (AF) were analyzed with 2 separate polymerase chain reaction (PCR) tests and with viral culture. For newborns, clinical examinations and pharyngeal HSV cultures were performed, and cord blood IgM antibodies to HSV were measured. HSV DNA was present in the AF of 3 women with symptomatic HSV infection, but all cultures were negative. HSV was detected more often with PCR than with culture, in both vesicle and cervical samples. For the asymptomatic group, all AF samples were negative, whereas 4 cervical samples were positive by PCR (none were positive by culture). All isolates were HSV type 2. All infants were healthy, and none had cord blood IgM antibodies to HSV, including those with PCRpositive AF.
Herpes Simplex Virus DNA in Amniotic Fluid without Neonatal Infection
Twenty-one pregnant women were studied to determine the distribution of herpes simplex virus (HSV): 10 had symptomatic genital herpes, including 1 with primary cervical HSV infection, and 11 had asymptomatic genital herpes. Samples from vesicles, the cervix, and amniotic fluid (AF) were analyzed with 2 separate polymerase chain reaction (PCR) tests and with viral culture. For newborns, clinical examinations and pharyngeal HSV cultures were performed, and cord blood IgM antibodies to HSV were measured. HSV DNA was present in the AF of 3 women with symptomatic HSV infection, but all cultures were negative. HSV was detected more often with PCR than with culture, in both vesicle and cervical samples. For the asymptomatic group, all AF samples were negative, whereas 4 cervical samples were positive by PCR (none were positive by culture). All isolates were HSV type 2. All infants were healthy, and none had cord blood IgM antibodies to HSV, including those with PCRpositive AF.
Genital herpes caused by herpes simplex virus (HSV) is one of the genital infections of clinical significance during pregnancy. Neonatal HSV infection, although rare, is severe and associated with high morbidity and mortality [1] [2] [3] [4] . Vaginal delivery from a mother with genital herpes is usually the route of neonatal infection. Alternatively, intrauterine HSV infection may be the source, or the newborn may contract HSV after birth (e.g., from orolabial transmission of HSV during handling).
Effective means of diminishing the risk of neonatal exposure to HSV in the birth canal include cesarean section [5, 6] and maternal acyclovir treatment, started before delivery to prevent HSV reactivation at the time of delivery [7, 8] . These measures, however, have little impact on the incidence of neonatal herpes, because the majority of cases involve neonates whose mothers are not aware of their infection [9] . In addition, 20%-30% of these infants are born by cesarean section, 8% with intact fetal membranes [10, 11] . Since true congenital herpes accounts for only about 5% of cases [12, 13] , the risk of neonatal HSV is not abolished by cesarean delivery.
We studied the distribution of HSV during pregnancy. Samples from lesions, the cervix, and amniotic fluid (AF) were taken from pregnant women during a symptomatic HSV episode and from asymptomatic women with known genital herpes. We also wanted to determine whether HSV could be detected in AF.
Our patients included women with first-episode HSV infection during pregnancy, 1 of whom proved to have a primary infection. We also examined 1 mother with no history of HSV infection, but whose previously born child had died of herpes encephalitis as a newborn. The samples were studied with viral culture and with 2 separate PCR tests, including a new modification of HSV PCR, in which HSV type 2 (HSV-2)-specific primers were included to distinguish between HSV-1 and -2.
Methods
Samples were taken from 21 healthy pregnant women with uncomplicated pregnancies. One woman had a twin pregnancy; all the others were singleton pregnancies. Clinical data are included in tables 1 and 2.
The samples were obtained from 10 women (patients 1-10; table 1) at the time of a symptomatic herpes episode. These included 1 patient (patient 1) who had primary HSV infection of the cervix but no external lesions and 2 patients (patients 5 and 9) who had clinically first-episode nonprimary HSV infections. The remaining 7 had symptomatic recurrent infections.
Ten women (patients 11-20; table 2) were studied while no symptoms were evident; their most recent symptomatic episode had occurred at least 3 weeks previously. One patient (patient 21) had never had symptomatic episodes of genital herpes. Her first pregnancy was uncomplicated, but the infant died at the age of 3 weeks of HSV encephalitis. She became pregnant again 2 months later and was tested 3 times, at the gestational ages of 9, 32, and 35 weeks.
Samples. Maternal samples for both viral culture and PCR were taken from vesicles, when present, from the cervix, and from AF with ultrasonographically directed transabdominal puncture through the upper part of the uterus. In addition, maternal serum antibodies (IgM and IgG) to HSV were analyzed. The samples were taken with informed consent and with the approval of the Ethics Committee of Turku University Hospital. AF samples were taken from 18 patients; 3 in the asymptomatic group refused. None of the women had any herpetic skin lesions outside the genitals. The AF samples were generally taken once, but a second sample was obtained from patient 1, to determine whether HSV DNA had appeared in the AF, and from patient 5, to verify the positive result. All newborns were examined clinically for herpetic lesions; in addition, pharyngeal HSV cultures were performed, and cord blood IgM antibodies to HSV were analyzed.
PCR for HSV DNA. The PCR test for HSV is a new, unpublished modification of a test for CSF samples [14] . The primers for HSV type 1 strains (5 -ATCACGGTAGCCCGGCCGTGT-GACA and 5 -CATACCGGAACGCACCACACAA) and the internal oligonucleotide probe (5 -TACGAGGAGGAGGGGTATA-ACAAAGTCTGT) were from the glycoprotein D gene of HSV-1 (gD-1) [14] . The primers for HSV-2 (5 -GCGGACCCACCGCAC-CACCATACTC and 5 -ACGGCGACTAGTGGTTCGCAATG-CA) were derived from the sequence of the glycoprotein D gene of HSV-2 (gD-2). The HSV-2 gD-2 internal probe was the same as for HSV-1. The lengths of the PCR products were 221 bp (HSV-1) and 172 bp (HSV-2).
The specimens were DNA extracts from vesicle and cervical swabs and AF. For PCR testing the contents of a swab were physically extracted into 500 mL of sterile saline solution. For each HSV type, 100 mL of the extract or AF were prepared for PCR by boiling for 15 min, followed by ethanol precipitation. The recovered DNA was diluted in 20 mL of sterile water and boiled for 10 min before testing. The positive controls were HSV-1 and HSV-2 virions, strains F and G, respectively (American Type Culture Collection, Bethesda, MD), containing 1 and 10 plaque-forming units (pfu) in PCR reaction. The dilutions were from high-titer stocks. Negative controls were distilled water. The working spaces for sample-handling, preparation of the reaction mixtures, and gel electrophoresis were all in separate rooms. The Finnpipette positive-displacement pipetting device (Labsystems, Espoo, Finland) was used for handling samples.
The PCR reaction mixture contained 200 mM of each deoxynucleotide, 20 picomoles of each primer, 1 U of polymerase (DynaZyme; Finnzymes, Espoo, Finland), and the buffer provided with the enzyme. The PCR reaction conditions were as follows: 95ЊC for 30 s, 55ЊC for 30 s, and 72ЊC for 60 s, for 40 cycles. An extra initial cycle with incubation at 95ЊC for 5 min was included. The last cycle included an incubation at 72ЊC for 5 min. The presence of the correct reaction product was observed both by ethidium bromide staining after electrophoresis in 2% agarose gel and by hybridization with a digoxigenin-labeled oligonucleotide probe. The detection procedure was done with radiography film by use of a luminescent reagent (CSPD; Boehringer, Mannheim, Germany).
The positive HSV gD PCR results were confirmed by PCR with glycoprotein B (gB) primers [15] . The gB PCR products were detected by means of agarose gel electrophoresis and subsequent Southern hybridization with a digoxigenin-labeled internal gB probe [15] .
Spike-back experiments were performed for detecting possible inhibitors in the negative AFs by adding a low amount of HSV-2 (4 pfu per PCR reaction) to the specimens before the DNA extraction.
HSV culture. Rapid HSV culture of the cervical and vesicle samples was carried out in mink lung cells by an immunoperoxidase staining method, as described elsewhere by Ziegler et al. [16] . The HSV cultures of AF were performed in vero cells and in human diploid fibroblasts [17] .
Serum HSV antibody assay. Assays for IgG and IgM antibodies to HSV envelope antigens were performed by indirect EIAs 
NOTE. EIU, enzyme immunoassay units (scale, 1-100); NA, not available; Ϫ, negative finding; ϩ, positive finding.
a Twin pregnancy.
according to standard protocols of the University of Turku Department of Virology, as described elsewhere by Ziegler et al. [18] .
Results
The results of the HSV cultures and PCR tests in the group of women with symptomatic genital herpes are presented in table 1. Four women had HSV-2 identified in cultures of vesicle samples, and 1 additional vesicle sample was positive by PCR. Cervical-specimen cultures from 2 women were HSV-positive and also PCR-positive. HSV DNA was found by PCR in the cervix in 3 additional cases. Patient 1, who had seroconversionproven primary HSV-2 infection at 33 weeks (table 3) , had a sample obtained from the cervix in the acute stage that was both culture-and PCR-positive. PCR was still positive 3 weeks later.
The most interesting finding was that in 3 patients the AF was positive for HSV by PCR ( figure 1 ). In all 3 cases PCR identified HSV-2. All culture results were negative. In case 5 the sampling was repeated after 1 week and the gD PCR was still positive, but the gB PCR had become negative. Two of these women (patients 5 and 9) had not previously had symptomatic genital herpes; both had bilateral lesions and slight systemic symptoms. Pre-existing IgG antibodies to HSV ruled out primary infection (table 3) .
Clinically, these HSV-2 infections would appear to be firstepisode nonprimary HSV infections (HSV-2 infections in persons with antibodies to HSV-1 are considered non-primary). Because reliable HSV type-specific antibody testing was not available, the diagnoses could not be serologically confirmed. Peroral acyclovir therapy had already been started before sampling; consequently, all other samples were negative. For the third patient with PCR-positive AF (patient 2), positive samples were obtained from vesicles (which were both culture-and PCR-positive) and from the cervix (only PCR-positive).
The findings for the 11 women whose samples were taken at the asymptomatic stage are presented in table 2. Four had positive PCR samples obtained from the cervix, although all the cultures were negative. These four included patient 21, who had a positive cervical sample obtained during early pregnancy but for whom repeated tests at weeks 32 and 35 were negative. All the AF samples were negative. In the spike-back experiments, no inhibition of PCR reaction was observed. Examples of profiles for PCR-positive cervical samples from both groups are shown in figure 2 .
All samples that were positive for HSV, whether by viral culture or by PCR, contained HSV-2. No HSV-1 was detected. All the newborns were healthy and had no symptoms. All had HSV-negative pharyngeal cultures, and no IgM antibodies to HSV were found in cord blood.
Discussion
In this study we analyzed the distribution of HSV during outbreaks of genital herpes in a group of pregnant women and showed that HSV DNA can be found in the AF during pregnancy even when the fetus is not infected.
The serological prevalence of HSV-2 varies according to the population studied but is ∼30% of pregnant women in the United States and Scandinavia [19] [20] [21] . As symptomatic genital herpes occurs in 2%-5% of women [22] , it must be concluded that the symptomatic form of the infection with external herpetic lesions accounts for only a fraction of the disease. Serological analysis suggests that 70%-90% of HSV-2 infections are asymptomatic, including most of the primary infections during pregnancy [23] [24] [25] .
Symptoms of an infection, like pain, swelling, burning, or itching, are mainly a consequence of the inflammatory response of the immune system. It is interesting to speculate whether the immunosuppression induced by pregnancy affects the immune response against HSV, which is dependent on cytotoxic CD8 ϩ T cells [26, 27] . Asymptomatic women with perhaps defective cellular responses might have larger numbers of or more prolonged periods with infective viruses in the birth canal, with a greater risk to the newborn.
Asymptomatic shedding of the virus in the birth canal is frequent in women with known HSV infection. HSV can be isolated at the time of delivery from 2% to 3% of women with either a known history of genital herpes or antibodies against HSV-2 [28, 29] . In our population, 40% of the asymptomatic women with known recurrent genital HSV infection were positive by PCR. All the culture results were negative, suggesting the absence of living viruses. It is well known that HSV DNA can be detected with PCR several days after the culture becomes negative [30] . PCR generally detects HSV 5-10 times more frequently than does viral culture [31] .
The majority of PCR-positive, culture-negative cases probably are due to replication-defective viruses or DNA fragments connected with viral elimination. Therefore, the incidence of true asymptomatic shedding cannot be estimated with PCR. On the other hand, PCR is also more sensitive for detection of live viruses [15] ; neonatal HSV infection is known to occur in cases involving culture-negative, PCR-positive asymptomatic mothers [31] .
Three of the 10 patients with acute herpes had PCR-positive AF. To exclude false-positive PCR results, the AF samples were studied with 2 separate PCR assays, and the PCR results were confirmed with Southern hydridization. Carryover contamination in the laboratory, which is the most common reason for false-positive PCR results, would in these cases require the contamination of 2 separate PCR assays, each done with appropriate negative and positive controls. False PCR amplification was excluded with the hydridization test.
In addition to the possibility of a false-positive PCR result, which we consider minimal, 2 possibilities remain to explain the positive AF findings. First, an intrauterine HSV infection may have occurred and been eliminated by the maternal IgG antibodies on the fetal side. This seems unlikely because HSV cultures of the AF were negative, and the newborns were all healthy, with no cord IgM antibodies to HSV. Congenital HSV infection is estimated to account for 4%-6% of all neonatal HSV infections. If infective herpesviruses were present in the AF in 30% of cases with HSV symptoms, as in our population, one would expect congenital neonatal HSV infection to be much more frequent. Two of the 3 women had received peroral acyclovir, which is known to cross the placental barrier. For the same reasons, it is unlikely that an intra-amniotic HSV infection was eliminated by transplacental acyclovir treatment.
The second possible explanation for the PCR-positive AF samples is that dead viruses or fragments of HSV DNA were carried into the AF (e.g., by maternal macrophages) from the site of the infection. As the gene loci of glycoproteins D and B reside entirely separately at distant sites of the circular HSV genome, the HSV DNA has to be intact or in large fragments for these 2 tests to be simultaneously positive. This is the first report of analysis of HSV from the AF of women with genital herpes. In order to characterize the state of HSV DNA, additional studies such as in situ hybridization are needed. In any case, HSV-positivity of PCR of the AF did not correlate with neonatal morbidity in our study. 
